BlueCrest Capital Management’s Pfizer PFE Stock Holding History

BlueCrest Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-87,036	Closed	-$2.42M	–	201
2024 Q1	$2.42M	Sell	87,036 -433,861	-83%	-$12M	0.12%	108
2023 Q4	$15M	Buy	520,897 +442,039	+561%	+$13.4M	0.57%	37
2023 Q3	$2.62M	Buy	78,858 +61,909	+365%	+$2.19M	0.12%	117
2023 Q2	$622K	Buy	+16,949	New	+$660K	0.02%	167
2019 Q4	–	Sell	-21,034	Closed	-$717K	–	539
2019 Q3	$717K	Buy	21,034 +13,693	+187%	+$498K	0.05%	228
2019 Q2	$302K	Sell	7,341 -279,682	-97%	-$11.1M	0.02%	280
2019 Q1	$11.6M	Buy	287,023 +134,133	+88%	+$5.37M	0.46%	26
2018 Q4	$6.33M	Buy	+152,890	New	+$6.35M	0.33%	57
2018 Q3	–	Sell	-459,132	Closed	-$15.8M	–	1732
2018 Q2	$15.8M	Buy	+459,132	New	+$15.7M	0.41%	33
2018 Q1	–	Sell	-7,385	Closed	-$254K	–	1600
2017 Q4	$254K	Buy	+7,385	New	+$252K	0.01%	661
2017 Q3	–	Sell	-40,096	Closed	-$1.28M	–	1037
2017 Q2	$1.28M	Sell	40,096 -132,974	-77%	-$4.19M	0.05%	422
2017 Q1	$5.62M	Buy	173,070 +88,737	+105%	+$2.8M	0.27%	113
2016 Q4	$2.6M	Buy	84,333 +72,429	+608%	+$2.21M	0.14%	216
2016 Q3	$383K	Buy	+11,904	New	+$398K	0.01%	580

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlueCrest Capital Management's PFE Position: Q2 2024 in Review

BlueCrest Capital Management sold out of Pfizer (PFE) in Q2 2024, closing a stake of 87,036 shares — an estimated $2.42M sold.

BlueCrest Capital Management first reported a position in PFE in Q3 2016 and held it in 14 quarters. The position peaked at $15.8M in Q2 2018. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

BlueCrest Capital Management reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
BlueCrest Capital Management sold 87,036 Pfizer shares in Q2 2024, an estimated $2.42M.
BlueCrest Capital Management first reported a position in Pfizer in Q3 2016 and held it in 14 quarters.
BlueCrest Capital Management's Pfizer position peaked at $15.8M in Q2 2018.
2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on BlueCrest Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.